Market Cap

Biogen Inc. Market Capitalization:

$20.94 Billion

USD as of Jan. 1, 2025

business Biogen Inc. Company Profile

Biogen Inc. Main Stock Listing

NASDAQ: BIIB

Market Capitalization History of Biogen Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $689.42 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B
Merck $244.44 B
Roche $219.35 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Yearly evolution of Biogen Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2025 $20.94 B -45.15%
Jan. 1, 2024 $38.17 B -2.77%
Jan. 1, 2023 $39.26 B 21.56%
Jan. 1, 2022 $32.30 B -20.03%
Jan. 1, 2021 $40.39 B 5.12%
Jan. 1, 2020 $38.42 B -19.45%
Jan. 1, 2019 $47.70 B -4.03%
Jan. 1, 2018 $49.70 B 25.45%
Jan. 1, 2017 $39.62 B 1.53%
Jan. 1, 2016 $39.02 B -29.83%
Jan. 1, 2015 $55.61 B 24.48%
Jan. 1, 2014 $44.68 B 100.31%
Jan. 1, 2013 $22.31 B 32.33%
Jan. 1, 2012 $16.86 B 80.16%
Jan. 1, 2011 $9.36 B 21.83%
Jan. 1, 2010 $7.68 B 10.46%
Jan. 1, 2009 $6.95 B -20.18%
Jan. 1, 2008 $8.71 B 26.09%
Jan. 1, 2007 $6.91 B 8.02%
Jan. 1, 2006 $6.40 B -31.11%
Jan. 1, 2005 $9.28 B 51.14%
Jan. 1, 2004 $6.14 B 33.98%
Jan. 1, 2003 $4.58 B -46.05%
Jan. 1, 2002 $8.50 B 1.10%
Jan. 1, 2001 $8.40 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Company Description

Biogen Inc. is a biotechnology company specialized in the treatment of neurological diseases. It researches, develops, and markets therapies for a range of diseases including Alzheimer’s disease, hemophilia, multiple sclerosis, spinal muscular atrophy, plaque psoriasis, leukemia, rheumatoid arthritis, lymphoma, neurocognitive disorders, and pain.

business Biogen Inc. Company Profile

Biogen Inc. Categories

United States languages Healthcare languages Drug Manufacturers—General
United States Healthcare United States Drug Manufacturers—General

Stocks & Indices

Biogen Inc. has the following listings and related stock indices.


Stock: NASDAQ: BIIB

Stock: BCBA: BIIB

Stock: BMV: BIIB

Stock: Bovespa: BIIB34

Stock: BVS: BIIB

Stock: FSX: IDP

Stock: MTA: BIIB.U

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.